Recombinant CD3E (Foralumab Biosimilar) antibody

Catalog No. ABIN7795098

The Humanized Monoclonal anti-CD3E (Foralumab Biosimilar) antibody has been validated for FACS and in vivo. It is suitable to detect CD3E (Foralumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD3E (Foralumab Biosimilar) antibody (ABIN7795098)

Target: CD3E (Foralumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD3E (Foralumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-CD3E (Foralumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Foralumab Biosimilar, Human CD3e Monoclonal Antibody

Characteristics: Foralumab Biosimilar uses the same protein sequences as the therapeutic antibody foralumab (humanized OKT3). A fully human monoclonal antibody that binds to CD3 epsilon of the T cell receptor-CD3 complex, Foralumab (humanized OKT-3) is used as immunosuppressive therapy in kidney, heart, and liver transplant patients.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: Human CD3e

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for CD3E (Foralumab Biosimilar)

Target: CD3E (Foralumab Biosimilar)

Alternative Name: Foralumab Biosimilar

Target Type: Biosimilar